Preferred Label : belimumab;

MeSH note : monoclonal antibody directed against human BLyS protein (B lymphocyte stimulator) for treatment of autoimmune diseases;

CISMeF synonym : LymphoStat-B;

MeSH hyponym : BEL114333; HGS1006; GSK1550188;

MeSH Related Number : 356547-88-1 (belimumab);

Registry Number MeSH : 356547-88-1;

Is substance : O;

UNII : 73B0K5S26A;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3313609/fr/benlysta-belimumab-glomerulonephrite-lupique
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
immunosuppressive agents
belimumab
adult
drug therapy, combination
Systemic lupus erythematosus glomerulonephritis syndrome, World Health Organization class III (disorder)
Systemic lupus erythematosus glomerulonephritis syndrome, World Health Organization class IV (disorder)
infusions, intravenous
injections, subcutaneous
evaluation of the transparency committee
belimumab
lupus nephritis

---
https://www.has-sante.fr/jcms/p_3191300/fr/benlysta
2020
false
false
false
France
belimumab
insurance, health, reimbursement
child
lupus erythematosus, systemic
immunosuppressive agents
treatment outcome
infusions, intravenous
evaluation of the transparency committee
belimumab
antibodies, monoclonal, humanized

---
BENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69506a-fra.php
2019
false
false
false
Canada
French
English
depressive disorder, major
belimumab
belimumab
self-injurious behavior
lupus erythematosus, systemic
pharmacovigilance note
patients guideline
risk assessment
antibodies, monoclonal, humanized

---
https://www.has-sante.fr/portail/jcms/c_2848657/fr/benlysta
2018
false
false
false
France
French
evaluation of the transparency committee
benlysta
belimumab
antibodies, monoclonal, humanized

---
http://www.has-sante.fr/portail/jcms/c_1751169/fr/benlysta
http://www.has-sante.fr/portail/jcms/c_1234522/benlysta
2014
false
France
French
evaluation of the transparency committee
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
guidelines for drug use
secondary prevention
corticosteroid therapy
belimumab
belimumab
antibodies, monoclonal
antibodies, monoclonal
belimumab
immunosuppressive agents
immunosuppressive agents
TNFSF13B protein, human
b-cell activating factor
lupus erythematosus, systemic
treatment outcome
drug therapy, combination
adult
infusions, intravenous
randomized controlled trials as topic
risk management
clinical trials, phase iii as topic
antibodies, antinuclear
Tumor Necrosis Factor Inhibitors

---
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/39189a-fra.php
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/39191a-fra.php
2014
Canada
French
belimumab
infusions, intravenous
belimumab
lupus erythematosus, systemic
leukoencephalopathy, progressive multifocal
immunosuppressive agents
pharmacovigilance note
patient education handout
antibodies, monoclonal, humanized

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65600733
2013
France
summary of product characteristics
powders
belimumab

---
http://www.cri-net.com/fiches-pratiques-et-recommandations/prise-en-charge-pratique-des-patients-sous-belimumab
2013
false
true
false
France
French
belimumab
belimumab
patient care management
continuity of patient care
belimumab
infusions, intravenous
lupus erythematosus, systemic
guidelines for drug use
practice guideline
consensus
patients guideline
dialysis
splenectomy
vaccination
surgical procedures, operative
pregnancy
immunosuppressive agents
immunosuppressive agents
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65592934
2013
France
summary of product characteristics
powders
belimumab

---
http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2012/14116a-fra.php
http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2012/15853a-fra.php
2012
Canada
French
English
antibodies, monoclonal, humanized
popular works
pharmacovigilance note
belimumab
belimumab
antibodies, monoclonal
infusions, intravenous
drug hypersensitivity
adult
lupus erythematosus, systemic
infusions, intravenous
risk
continuity of patient care

---
http://www.has-sante.fr/portail/jcms/c_1269668/benlysta-belimumab-anticorps-monoclonal-inhibant-lactivation-des-cellules-b
2012
France
French
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
guidelines for drug use
corticosteroid therapy
rare diseases
orphan drug production
infusions, intravenous
belimumab
belimumab
antibodies, monoclonal
antibodies, monoclonal
belimumab
treatment outcome
randomized controlled trials as topic
lupus erythematosus, systemic
immunosuppressive agents
immunosuppressive agents
adult
drug therapy, combination

---
https://www.ema.europa.eu/medicines/human/EPAR/Benlysta
2012
United Kingdom
English
French
summary of product characteristics
package leaflet
drug evaluation
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
syndication feed
belimumab
belimumab
drug approval
treatment outcome
infusions, intravenous
adult
lupus erythematosus, systemic
antibodies, monoclonal
antibodies, monoclonal
belimumab
b-cell activating factor
TNFSF13B protein, human
Tumor Necrosis Factor Inhibitors

---
Nous contacter.
29/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.